Tributyltin increases the expression of apoptosis- and adipogenesis-related genes in rat ovaries

Hyojin Lee1, Sojeong Lim, Sujin Yun

  • 1Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University, Seoul, Korea.

Abstract

Insights

Tributyltin (TBT) exposure increases adipogenesis and apoptosis genes in rat ovaries, leading to ovarian dysfunction. This endocrine disruptor causes ovarian follicle apoptosis, impacting reproductive health.

Area of Science:

  • Endocrinology
  • Toxicology
  • Reproductive Biology

Background:

  • Tributyltin (TBT) is an endocrine-disrupting chemical known to impair ovarian function.
  • The precise mechanisms by which TBT induces ovarian apoptosis remain incompletely understood.

Purpose of the Study:

  • To investigate if TBT exposure upregulates adipogenesis-related genes in the ovary.
  • To determine if this upregulation is linked to TBT-induced apoptosis and subsequent loss of ovarian function.

Main Methods:

  • Administration of TBT (1 or 10 mg/kg) or control (sesame oil) to Sprague-Dawley rats for 7 days.
  • Ovarian weight measurement, TUNEL assay for apoptosis, and real-time PCR for gene expression analysis (adipogenesis and apoptosis markers).

Main Results:

  • TBT administration (10 mg/kg) significantly reduced ovarian weight and increased ovarian follicle apoptosis.
  • TBT exposure upregulated key adipogenesis genes (PPARγ, aP2, CD36, PEPCK) and apoptosis-related genes (TNFα, TNFR1).

Conclusions:

  • TBT induces adipogenesis and apoptosis gene expression in ovarian follicles, leading to apoptosis.
  • Increased adipogenesis gene expression by TBT exposure may drive apoptosis, contributing to ovarian dysfunction.

Related Concept Videos